SCHEMBL24154196

SCHEMBL24154196

Cc1cc(-c2ccc(-c3ccc(Oc4[nH]nnc4C(=O)O)cc3)cc2)ccn1

nearest known ligand 0.48

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
DYRK1A Q13627 1/20 0.48
HAO1 Q9UJM8 4/20 0.47
PORCN Q9H237 3/20 0.46
CCNC P24863 1/20 0.41
CDK8 P49336 1/20 0.41
PRKAG1 P54619 1/20 0.39
PRKAA1 Q13131 1/20 0.39
PRKAB1 Q9Y478 1/20 0.39
WNT3A P56704 5/20 0.39
PSEN1 P49768 3/20 0.39
PSEN2 P49810 3/20 0.39
APH1B Q8WW43 3/20 0.39
NCSTN Q92542 3/20 0.39
APH1A Q96BI3 3/20 0.39
PSENEN Q9NZ42 3/20 0.39
ROCK2 O75116 1/20 0.37
ROCK1 Q13464 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29968208 1.00 DYRK1A (0.48) DYRK1AHAO1PORCNCCNCCDK8
SCHEMBL31166180 1.00 DYRK1A (0.48) DYRK1AHAO1PORCNCCNCCDK8
SCHEMBL23319895 1.00 DYRK1A (0.48) DYRK1AHAO1PORCNCCNCCDK8
SCHEMBL25463836 0.86 PRKAG1 (0.37) HAO1PORCNPRKAG1PRKAA1PRKAB1
SCHEMBL23319946 0.86 PRKAG1 (0.37) HAO1PRKAG1PRKAA1PRKAB1WNT3A
SCHEMBL21296970 0.83 ALPL (0.42) HAO1PRKAG1PRKAA1PRKAB1
SCHEMBL23319995 0.83 HAO1 (0.46) HAO1CCNCCDK8PRKAG1PRKAA1
SCHEMBL23320006 0.83 HAO1 (0.46) HAO1CCNCCDK8PRKAG1PRKAA1
SCHEMBL23319935 0.83 HAO1 (0.48) HAO1PRKAG1PRKAA1PRKAB1
SCHEMBL23001685 0.83 HAO1 (0.70) HAO1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230143491-A1 TRIAZOLE GLYCOLATE OXIDASE INHIBITORS PHOENIX TISSUE REPAIR, INC. 2023-05-11 US disclosed
US-20230143491-A1 TRIAZOLE GLYCOLATE OXIDASE INHIBITORS PHOENIX TISSUE REPAIR, INC. 2023-05-11 US disclosed
US-20210403439-A1 TRIAZOLE GLYCOLATE OXIDASE INHIBITORS VENTHERA, INC. 2021-12-30 US disclosed
CN-112399873-A Triazole glycolate oxidase inhibitor 奥凡生物科技公司 2021-02-23 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230143491-A1 TRIAZOLE GLYCOLATE OXIDASE INHIBITORS XDH, DUOX1, PNPO DYRK1A 1344/4885HAO1 6/4885PORCN 2040/4885
US-20210403439-A1 TRIAZOLE GLYCOLATE OXIDASE INHIBITORS XDH, DUOX1, PNPO DYRK1A 1344/4885HAO1 6/4885PORCN 2040/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.